Financial burden impact quality of life among lymphatic Filariasis patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
    • Abstract:
      Background: Human lymphatic filarial pathology is the leading cause of disability and poverty among people living with the infection. The second goal of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) is to manage the disease's morbidity to improve patients' quality of life. Consequently, the current study assessed the overall quality of life of lymphatic filariasis (LF) pathology patients in some selected endemic communities in rural Ghana.
      Method: In the present study, the Lymphatic Filariasis Quality of Life Questionnaire (LFSQQ) was used to evaluate the effect of lymphatic filariasis on the quality of life of people, with the disease in nine (9) communities in the Ahanta West District of the Western Region of Ghana where mass drug administration is being implemented for the past twenty years. Pearson's correlation, linear regression, and one-way analysis of variance (ANOVA) analyses were used to assess the associations between the LFSQQ instrument domains.
      Results: Of the 155 study participants recruited, 115 (74.19%) were females, and 40 (25.81%) males. A greater proportion of the study participants (40, 25.8%) were presented with stage two (2) lymphoedema, while only two patients had stage seven (7) lymphoedema. The average of the overall quality of life scores of study participants was 68.24. There was a negative Pearson correlation (r = - 0.504, p-value < 0.001) between the stage of lymphoedema (severity of the disease) and the quality of life of the LF patients. In addition, a clear pattern of positive correlation (r = 0.71, p-value < 0.001) was observed between the disease burden and pain/discomfort domains of the study participants. Whereas the highest domain-specific score (85.03) was observed in the domain of self-care, we noted that the environmental domain, which consists of the financial status, was the lowest (45.94) among the study participants.
      Conclusion: Our findings support previous works on the reduced quality of life among lymphatic filariasis patients with pathology. In this study, our results reveal a depressing financial condition among people presenting with late stages of LF pathologies, which eventually reduces their well-being.
    • References:
      PLoS Negl Trop Dis. 2019 Dec 12;13(12):e0007840. (PMID: 31830026)
      J Infect Dis. 1993 May;167(5):1178-83. (PMID: 8486952)
      Infect Dis Poverty. 2017 Apr 3;6(1):28. (PMID: 28366168)
      Trans R Soc Trop Med Hyg. 2007 Apr;101(4):391-7. (PMID: 17112555)
      Trop Med Int Health. 1998 Jun;3(6):467-73. (PMID: 9657509)
      PLoS Negl Trop Dis. 2007 Nov 21;1(2):e128. (PMID: 18060080)
      Trans R Soc Trop Med Hyg. 2007 Mar;101(3):245-9. (PMID: 17098268)
      J Trop Med Hyg. 1993 Oct;96(5):317-22. (PMID: 8411308)
      Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):634-8. (PMID: 9015499)
      BMC Infect Dis. 2019 May 20;19(1):442. (PMID: 31109288)
      Ann N Y Acad Sci. 2008;1136:53-63. (PMID: 18579875)
      Br J Dermatol. 2006 May;154(5):933-41. (PMID: 16634898)
      Trans R Soc Trop Med Hyg. 1996 Jan-Feb;90(1):26-30. (PMID: 8730304)
      Trop Med Int Health. 2005 Jun;10(6):567-73. (PMID: 15941420)
      Lymphat Res Biol. 2016 Mar;14(1):2-7. (PMID: 26982711)
      Acta Trop. 2013 Jun;126(3):198-204. (PMID: 23499714)
      PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2716. (PMID: 24587467)
    • Contributed Indexing:
      Keywords: Ghana; Lymphatic Filariasis; Quality of life
    • Publication Date:
      Date Created: 20210122 Date Completed: 20210514 Latest Revision: 20210514
    • Publication Date:
      20240105
    • Accession Number:
      PMC7818560
    • Accession Number:
      10.1186/s12889-021-10170-8
    • Accession Number:
      33478462